ImmuneWorks' Unattributed VC Round

ImmuneWorks raised a round of funding on October 05, 2007. Investors include BioCrossroads.

ImmuneWorks is a clinical stage biotechnology company developing a therapeutic asset for idiopathic pulmonary fibrosis (IPF) and additional fibrotic lung diseases.…

Articles about ImmuneWorks' Unattributed VC Round: